Nephrotoxic renal injury, and especially drug nephrotoxicity is now a common cause of acute renal failure. The most common patterns of renal injury produced by nephrotoxins, tubular damage, and interstitial nephritis, are discussed here. Toxic agents which are primarily tubular toxins include certain antibiotics, cis-platinum, anesthetics, and radiocontrast agents. In tubules injured by toxins, alterations range from subtle ultrastructural abnormalities to extensive tubular necrosis. Mechanisms of tubular injury include direct tubular cell toxicity, and alterations in intrarenal blood flow producing secondary tubular damage. Other commonly used therapeutic agents, including the penicillins, other antibiotics, and non-steroidal anti-inflammatory agents, produce renal dysfunction by inducing interstitial nephritis. Long-term analgesic abuse is associated with a particularly striking interstitial damage with frank papillary necrosis. Criteria for differentiating primary tubular injury with inflammation and primary interstitial nephritis with tubular injury are discussed. Individual commonly-used therapeutic agents are considered in some detail, with discussion of both clinical and morphological aspects of drug nephrotoxicity.
References
1.
1. Aggarwal SK, Whitehouse MW, and Ramachandran C (1980). Cis-platinum, Current Status and New Development.Academic Press, New York, pp. 79–111.
2.
2. Ansari Z and Baldwin DS (1976). Acute renal failure due to radiocontrast agents. Nephron17:28–40.
3.
3. Appel GB and Neu HC (1977). The nephrotoxicity of antimicrobial agents. N. Engl. J. Med.296:663–670.
4.
4. Arisz L, Donker AJM, Brentjens JHR, and van der Hem GK (1976). The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med. Scand.199:121–125.
5.
5. Baldwin DS, Levine BB, McCluskey RT, and Gallo GR (1968). Renal failure and interstitial nephritis due to penicillin and methicillin. N. Engl. J. Med.279:1245–1252.
6.
6. Barza M (1978). The nephrotoxicity of cephalosporins: An overview. J. Infect. Dis.137: S60–S73.
7.
7. Baylis C, Rennke HR, and Brenner BM (1977). Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration. Kidney Int.12:344–353.
8.
8. Bender WL, Whelton A, Beschorner WE, Darwish MO, Hall-Craggs M, and Solez K (1984). Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs: Immunologic characterization of the inflammatory infiltrate. Am. J. Med.76:1006–1012.
9.
9. Bennett WM, Plamp C, and Porter GA (1977). Drug-related syndromes in clinical nephrology. Ann. Int. Med.87:582–590.
10.
10. Berkseth RO and Kjellstrand CM (1984). Radiologic contrast-induced nephropathy. Med. Clin. N. Am.68:351–370.
11.
11. Blasingham MC and Nasjletti A (1980). Differential renal effects of cyclooxygenase inhibition in sodium-replete and sodium-deprived dogs. Am. J. Physiol.239: F360–F365.
12.
12. Blythe WB and Woods JW (1961). Acute renal insufficiency after ingestion of a gallbladder dye. N. Engl. J. Med.264:1045–1046.
13.
13. Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, and Wilson CB (1974). Antitubular basement membrane antibodies in methicillin-associated interstitial nephritis. N. Engl. J. Med.291:381–384.
14.
14. Boyer TD, Zia P, and Reynolds TB (1979). Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology77:215–222.
15.
15. Brandstetter RD and Mar DD (1978). Reversible oliguric renal failure associated with ibuprofen treatment. Br. Med. J.2:1194–1195.
16.
16. Brauninger GR and Remington JS (1968). Nephropathy associated with methicillin therapy. J.A.M.A.203:103–105.
17.
17. Brezin JH, Katz SM, Schwartz AB, and Chinitz JL (1979). Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N. Engl. J. Med.30:1271–1273.
18.
18. Broomhead JA, Fairlie DP, and Whitehouse MW (1980). Cis-platinum (11) amine complexes: Some structure-activity relationships for immunosup-pressive, nephrotoxic and gastrointestinal (side) effects in rats. Chem. Biol. Inter.31:113–132.
19.
19. Bullock WE, Luke RG, Vuttall CE, and Bhathena D (1976). Can mannitol reduce amphotericin B nephrotoxicity? Doubleblind study and description of new vascular lesion. Antimicrob. Agents Chemother.10:555–563.
20.
20. Butler WT, Hill GJ II, Szwed CF, and Knight V (1964). Amphotericin B nephrotoxicity in the dog. J. Pharmacol Exp. Ther.143:47–56.
21.
21. Campese VM, Marzullo F, Schena FP, and Corotelli P (1973). Acute renal failure during intermittent rifampicin therapy. Nephron10:256–261.
22.
22. Chatterjee GP (1981). Nephrotic syndrome induced by tolmetin. J.A.M.A.246: 1589.
23.
23. Choie DD, Del Campo AA, and Guarino A (1980). Subcellular localization of cis-dichlorodiammine-phatinum (II) in rat kidney and liver. Toxicol. Appl. Pharmacol.55:245–252.
24.
24. Clive DM and Stoff JS (1984). Renal syndromes associated with nonsteroidal antiinflammatory drugs. N. Engl. J. Med.340:563–569.
25.
25. Cochran M, Moorhead PJ, and Platts M (1975). Permanent renal damage with rifampicin. Lancet1: 1428.
26.
26. Cochran ST, Waisman J, Pagani JJ, and Cahill P (1982). Nephrotoxicity of epinephrine-assisted venography. Invest. Radiol.17:583–592.
27.
27. Colvin RB, Burton JR, Hyslop NE Jr, Spitz L, and Lichtenstein NS (1974). Penicillin-associated interstitial nephritis. Ann. Intern. Med.81:404–405.
28.
28. Cotton JR Jr, Schwartz MM, Lindley JD, and Hun-sicker LG (1976). Acute renal failure following halothane anesthesia. Arch. Pathol. Lab. Med.100:628–629.
29.
29. Cove-Smith JR (1981). Analgesic nephropathy in the United Kingdom: Incidence, clinical features, and pathogenesis. J. Clin. Pathol.34:1255–1260.
30.
30. Cramer BC, Parfrey PS, Hutchinson TA, Baran D, Melanson DM, Ethier RE, and Seely JF (1985). Renal function following infusion of radiologic contrast material. Arch. Intern. Med.145:87–89.
31.
31. Curt GA, Kaldany A, Whitley LG, Crosson AW, Rolla A, Merino MJ, and D'Elia JA (1980). Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium. Ann. Intern. Med.92:72–73.
32.
32. Dawborn JK, Fairly KF, Kincaid-Smith P, and King WE (1966). The association of peptic ulceration, chronic renal disease, and analgesic abuse. Quart. J. Med.35:69–83.
33.
33. D'Elia JA, Gleason RE, Alday M, Malarick C, Godley K, Warram J, Kaldany A, and Weinrauch LA (1982). Nephrotoxicity from angiographic contrast material: A prospective study. Am. J. Med.72:719–725.
34.
34. Dentino M, Luft FC, Yum MN, Williams SD, and Einhom LH (1978). Long-term effect of cis-diam-minedichloride platinum (CDDP) on renal function and structure in man. Cancer41:1274–1281.
35.
35. DcSimone PA, Yancey RS, Coupal JJ, Butts JD, and Hoeschel JD (1979). Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammine platinum (II). Cancer Treat. Rep.63:951–960.
36.
36. Dobyan DC, Levi J, Jacobs C, Kosek J, and Weiner NW (1980). Mechanisms of cis-platinum nephrotoxicity. II. Morphologic observations. J. Pharmacol. Exp. Ther.7:551–556.
37.
37. Dobyan DC, Hill D, Lewis T, and Bulger RE (1981). Cyst formation in rat kidney induced by cis-platinum administration. Lab. Invest.45:260–268.
38.
38. Drug Utilization in the U.S. by Categories, 1981. Third Annual Review, Washington, D.C., National Center of Drugs and Biologics, Table V, 1982, p. 17.
39.
39. Duggan FJ and Rohner TJ Jr (1973). Acute renal insufficiency following oral cholecystography. J. Urol.109:156–159.
40.
40. Einhom LH and Williams SD (1979). The role of cis-platinum in solid tumor therapy. N. Engl. J. Med.300:289–291.
41.
41. Eisenberg RL, Bank WO, and Hedgcock MW (1980). Renal failure after major angiography. Am. J. Med.68:43–46.
42.
42. Eknoyan G, Bulger RE, Purcell DJ II, and Dobyan DC (1984). Ultrastructural functional-anatomic correlations in acute renal failure and normal variations in endothelial morphology. In: Acute Renal Failure: Correlations Between Morphology and Function, K Solez and A Whelton (eds). Marcel Dekker, Inc., New York, pp. 105–117.
43.
43. Elliott WC, Houghton DC, Gilbert DN, Baines-Hunter J, and Bennett WM (1982). Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity. J. Lab. Clin. Med.100:501–512.
44.
44. Farnsworth A, Hall BM, Ng AB, Duggin GG, Horvath JS, Sheil AGR, and Tiller DJ (1984). Renal biopsy morphology in renal transplantation. A comparative study of the light microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine-prednisone and antilymphocyte globulin. Am. J. Surg. Pathol.8: 243.
45.
45. Favre L, Glasson P, and Vallotton MB (1982). Reversible acute renal failure from combined triamterene and indomethacin: A study in healthy subjects. Ann. Intern. Med.96:317–320.
46.
46. Feigin RD and Fiascone A (1965). Hematuria and proteinuria associated with methicillin administration. N. Engl. J. Med.272:903–904.
47.
47. Fellner SK and Tuttle EP (1969). The clinical syndrome of analgesic abuse. Arch. Intern. Med.124:379–382.
48.
48. Fernandez-Repollet E and Finn WF (1984). Relative importance of volume depletion and tubular damage in gentamicin-induced acute renal failure. In: Acute Renal Failure: Correlations Between Morphology and FunctionK Solez and A Whelton (eds). Marcel Dekker, Inc., New York, pp. 235–248.
49.
49. Finkelstein A, Fraley DS, Stachwa I, Feldman HA, Gandy DR, and Bourke E (1982). Fenoprofen nephropathy: lipid nephrosis and interstitial nephritis: A possible T-lymphocyte disorder. Am. J. Med.72:81–87.
50.
50. Frascino JA, Vanamee P, and Rosen PP (1970). Renal oxalosis and azotemia after methoxyflurane anesthesia. N. Engl. J. Med.283:676–679.
51.
51. Gabow PA, Lacher JW, and Neff TA (1976). Tubulointerstitial and glomerular nephritis associated with rifampicin. J.A.M.A.235:2517–2518.
52.
52. Gary NE, Dodelson R, and Eisinger RP (1980). Indomethacin-associated acute renal failure. Am. J. Med.69:135–136.
53.
53. Gault MH, Rudwal TC, Engles WD, and Posseter JB (1968). Syndrome associated with the abuse of analgesics. Ann. Intern. Med.68:906–925.
54.
54. Genkins G, Uhr JW, and Bryer MS (1954). Bacitracin nephropathy. Report of a case of acute renal failure and death. J.A.M.A.155:894–897.
55.
55. Goldstein RS and Mayor GH (1983). Minireview. The nephrotoxicity of cis-platinum. Life Sci.32:685–690.
56.
56. Gonzalez-Vitale JC, Hayes DM, Cvitkovic E, and Sternberg SS (1977). The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer39:1362–1371.
58. Graziano J, Jones B, and Pisciotto P (1981). The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammine platinum II administration to the rat. Brit. J. Pharmacol.73:649–654.
59.
59. Hansen ES and Tauris P (1976). Methicillin-induced nephropathy. A case with linear deposition of IgG and C3 on the tubular basement membrane. Acta Pathol. Microbiol. Scand. [A]84: 440–442.
60.
60. Harkonen S and Kjellstrand C (1981). Contrast nephropathy. Am. J. Nephrol.1: 69.
61.
61. Hartman GW, Torres VE, Leago GF, Williamson B Jr, and Hattery RR (1984). Analgesic-associated nephropathy: Pathophysiological and radiological correlation. J.A.M.A.251:1734–1738.
62.
62. Hayes DE, Cvitkovic E, Golby W, Scheiner E, Helson L, and Krakoff IH (1977). High dose cis-platinum diamminedichloride amelioration of renal toxicity by mannitol diuresis. Cancer39:1372–1381.
63.
63. Henrich WL, Anderson RJ, Berns AS, McDonald KM, Paulsen PJ, Berl T, and Schrier RD (1978). The role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog. J. Clin. Invest.61:744–750.
64.
64. Hestbech J, Hansen HE, Amdisen A, and Olsen S (1977). Chronic renal lesions following long-term treatment with lithium. Kidney Int.12:205–213.
65.
65. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, and Harrington JT (1983). Hospital-acquired renal insufficiency: A prospective study. Am. J. Med.74:243–248.
66.
66. Houghton DC, Campbell-Boswell MV, Bennett WM, Porter GA, and Brooks RE (1978). Myeloid bodies in the renal tubules of humans: Relationship to gentamicin therapy. Clin. Nephrol.10:140–145.
67.
67. Houghton DC, Plamp CE, DeFehr JM, Bennett WM, Porter G, and Gilbert D (1978). Gentamicin and tobramycin nephrotoxicity: A morphologic and functional comparison in the rat. Am. J. Pathol.93:137–146.
68.
68. Hruban Z, Slesers A, and Hopkins E (1972). Drug-induced and naturally occurring myeloid bodies. Lab. Invest.27:62–70.
69.
69. Katz SM, Sufian S, and Matsumoto T (1979). Urinary myelin figures in gentamicin nephrotoxicity. Am. J. Clin. Pathol.72:621–624.
70.
70. Kincaid-Smith P, Saker BM, McKenzie IFC, and Muriden KD (1968). Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med. J. Austr.1:203–206.
71.
71. Kirschenbaum MA, White N, Stein JH, and Ferris TF (1974). Redistribution of renal cortical blood flow during inhibition of prostaglandin synthesis. Am. J. Physiol.227:801–805.
72.
72. Kleinknecht C, Broyer M, Gubler M-C, and Palcoux J-B (1980). Irreversible renal failure after indo-methacin in steroid-resistant nephrosis. N. Engl. J. Med.302: 691.
73.
73. Kleinknecht D, Homberg JC, and Decroix G (1972). Acute renal failure after rifampicin. Lancet1:1238–1239.
74.
74. Kleinknecht D, Junges P, and Fillastre JP (1974). Nephrotoxicity of cephaloridine. Ann. Intern. Med.80:421–422.
75.
75. Kone BC, Racusen LC, Whelton A, and Solez K (1985). Acute renal failure produced by combining cyclosporine and brief renal ischemia in the Munich-Wistar rat. Clin. Nephrol, (in press).
76.
76. Kosek JC, Mazze RI, and Cousins MJ (1974). Nephrotoxicity of gentamicin. Lab. Invest.30:48–57.
77.
77. Kovnat P, Labovitz E, and Levison SP (1973). Antibiotics and the kidney. Med. Clin. N. Am.57:1045–1063.
78.
78. Krakoff IH (1979). Nephrotoxicity of cis-dichlorodiammine platinum (II). Cancer Treat. Rep.63:1523–1525.
79.
79. Krunlovsky FA, Simon N, Santhanam S, del Greco F, Roxe D, and Pomaranc MM (1978). Acute renal failure: Association with administration of radiographic contrast material. J.A.M.A.239:125–127.
80.
80. Kumar S, Hull JD, Lathi S, Cohen AJ, and Pletka PG (1981). Low incidence of renal failure after angiography. Arch. Intern. Med.141:1268–1270.
81.
81. Kuo CH, Maita K, Sleight SD, and Hook JB (1983). Lipid peroxidation: A possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol. Appl. Pharmacol.67:78–88.
82.
82. Levi J, Jacobs C, Kalman SM, McTigue M, and Weiner MW (1980). Mechanisms of cis-platinum nephrotoxicity. I. Effects of sulfhydryl groups in rat kidneys. J. Pharmacol. Exp. Titer.213:545–550.
83.
83. Lippman AJ, Helson C, Helson L, and Krakoff IH (1975). Cinical trials with cis-diamminedichloro platinum. Cancer Chemother. Rep.57:191–200.
84.
84. Lipsett MB and Goldman R (1954). Phenylbutazone toxicity: Report of a case of acute renal failure. Ann. Intern. Med.41:1075–1079.
85.
85. Luft FC and Evan AP (1980). Comparative effects of tobramycin and gentamicin on glomerular ultra-structure. J. Infect. Dis.142:910–914.
86.
86. Lullman H, Lullman-Ranch R, and Wasserman O (1975). Drug-induced phospholipidoses. CRC Critical Rev. Toxicol.4:185–218.
87.
87. Macklon AF, Craft AW, Thompson M, and Kerr DNS (1974). Aspirin and analgesic nephropathy. Br. Med. J.1:597–600.
88.
88. Madias NE and Harrington ST (1978). Platinum nephrotoxicity. Am. J. Med.65:307–314.
89.
89. Maher JF (1984). Analgesic nephropathy. Am. J. Med.76:345–348.
90.
90. Mandell GL (1973). Cephaloridine. Ann. Intern. Med.79:561–565.
91.
91. McAnally JF, Winchester JF, and Schreiner GE (1983). Analgesic nephropathy: An uncommon cause of end-stage renal disease. Arch. Intern. Med.143:1897–1899.
92.
92. McCarthy JT, Torres VE, Romero JC, Wochos DN, and Velosa JA (1982). Acute intrinsic renal failure induced by indomethacin: Role of prostaglandin synthetase inhibition. Mayo Clin. Proc.57:289–296.
93.
93. McCurdy DK, Frederick M, and Elkinton JR (1968). Renal tubular acidosis due to amphotericin B. N. Engl. J. Med.278:124–131.
94.
94. McMurtry RJ and Mitchell JR (1977). Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. Toxicol. Appl. Pharmacol.42:285–300.
95.
95. Merrin C (1976). A new method to prevent toxicity with high doses of cis-diammineplatinum. Proc. Am. Assoc. Cancer Res.17: 243.
96.
96. Mihatsch MJ, Olivieri W, Marbet U, Thiel G, Harder F, and Zollinger HU (1981). Giant mitochondria in renal tubular cells and cyclosporin A. (Letters. Lancet1: 1162–1163.
97.
97. Mihatsch MJ, Thiel G, Spichtin HP, Oberholzer M, Brunner FP, Harder F, Olivieri V, Bremer R, Ryffel B, Stocklin E, Torhorst J, Gudat F, Zollinger HU, and Loertscher R (1984). Morphologic findings in kidney transplants after treatment with cyclosporine. In: Cyclosporine: Biological Activity and Clinical Application, BD Kahan (ed). Grune and Stratton, New York, Vol. 1, p. 605.
98.
98. Mitchell JR, McMurtry RJ, Chatham CN, and Nelson SD (1977). Molecular basis for several drug-induced nephropathies. Am. J. Med.62:518–526.
99.
99. Moreau JF, Droz D, Sabto J, Jungers P, Kleinknecht D, Hinglais N, and Michel JR (1975). Osmotic nephrosis induced by water soluble tri-iodinated contrast media in man. A retrospective study of 47 cases. Radiology115:329–336.
100.
100. Morin JP, Viotle G, Vanderwalle A, Van Hoof F, Tulkens P, and Fillastre JP (1980). Gentamicin-induced nephrotoxicity: A cell biology approach. Kidney Int.18:583–590.
101.
101. Mudge GH (1971). Uricosuric action of cholecys-tographic agents: A possible factor in nephrotoxicity. N. Engl. J. Med.284:929–933.
103. Murray T and Goldberg M (1975). Analgesic abuse and renal disease. Ann. Rev. Med.26:537–550.
104.
104. Muther RS, Potter DM, and Bennett WM (1981). Aspirin-induced depression of glomerular filtration rate in normal humans: Role of sodium balance. Ann. Intern. Med.94:317–321.
105.
105. Myers BD, Ross J, Newton L, Luetscher J, and Perlroth M (1984). Cyclosporine-associated chronic nephropathy. N. Engl. J. Med.311: 699.
106.
106. Nanra RS (1980). Clinical and pathologic aspects of analgesic nephropathy. Br. J. Clin. Pharmacol.10(Suppl. 2): 359S–368S.
107.
107. Neugarten J, Aynedjian HS, and Bank N (1983). Role of tubular obstruction in acute renal failure due to gentamicin. Kidney Int.24:330–335.
108.
108. Oliver JA, Pinto J, Sciacca RR, and Cannon PJ (1980). Increased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dog. J. Clin. Invest.66:748–756.
109.
109. Oliver J A, Sciacca RR, Pinto J, and Cannon PJ (1981). Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J. Clin. Invest.67:229–237.
110.
110. Olsen S and Solez K (1982). Pathology of drug nephrotoxicity in humans. In: The Aminoglycosides: Microbiology, Clinical Use, and Toxicology, A Whelton and H Neu (eds). Marcel Dekker, Inc., New York, pp. 355–385.
111.
111. Pasternak DP and Stephens BG (1975). Reversible nephrotoxicity associated with cephalothin therapy. Arch. Intern. Med.135:599–602.
112.
112. Peters GA, Moskowitz RW, Prickman LE, and Carryer HM (1960). Fatal necrotizing angiitis associated with hypersensitivity to penicillin O and iodides. Report of a case. J. Allergy31:455–467.
113.
113. Poole G, Stradling P, Worlledge S (1971). Potentially serious side effects of high-dose twice-weekly rifampicin. Br. Med. J.3:343–347.
114.
114. Postlewaite AE and Kelley WN (1971). Uricosuric effect of radiocontrast agents. Ann. Intern. Med.74:845–852.
115.
115. Ramgopal V, Leonard C, and Bhathena D (1973). Acute renal failure associated with rifampicin. Lancet1:1195–1196.
116.
116. Rennke HG, Roos PC, and Wall SG (1980). Drug-induced interstitial nephritis with heavy glomerular proteinuria. N. Engl. J. Med.302:691–692.
117.
117. Reynolds ES, Tomkiewicz ZM, and Dammin GJ (1963). The renal lesion related to amphotericin B therapy for coccidiomycosis. Med. Clin. N. Am.47: 1149.
118.
118. Rosenthal T and Boichis H (1971). Nephrotoxicity of cephaloridine. Br. Med. J.4: 115.
119.
119. Ryffel B (1986). Cyclosporin toxicity. Toxicol. Pathol. (in press).
120.
120. Safirstein R, Miller P, Dikman S, Lyman N, and Shapiro C (1981). Cis-platinum nephrotoxicity in rats: Defect in papillary hypertonicity. Am. J. Physiol241: F175–F185.
121.
121. Schaeppi V, Heyman I A, and Fleischman RW (1973). Cis-dichlorodiammine platinum (II) (NSC-119875): Preclinical toxicologic evaluation of intravenous injection in dogs, monkeys, and mice. Toxicol. Appl. Pharmacol.25:230–241.
122.
122. Schilsky RL and Anderson T (1978). Hypomagnasemia and renal magnesium wasting in patients receiving cis-platinum. Ann. Intern. Med.90:929–931.
123.
123. Schrier RW, Bulger RJ, Van Arsdel PP Jr (1966). Nephropathy associated with penicillin and homologues. Ann. Intern. Med.64:116–127.
124.
124. Schor N, Ichikawa I, Rennke HG, Troy JL, and Brenner BM (1981). Pathology of altered glomerular function in aminoglycoside-treated rats. Kidney Int.19:288–296.
125.
125. Setter JG, Maher JF, and Schreiner GE (1963). Acute renal failure following cholecystography. J.A.M.A.184:116–120.
126.
126. Silverblatt F, Turck M, and Bulger R (1970). Nephrotoxicity due to cephaloridine: A light- and electron-microscopic study in rabbits. J. Infect. Dis.122:33–44.
127.
127. Silverblatt FJ and Kuehn D (1979). Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int.15:335–345.
128.
128. Simmons GF, Bogosky RT, and Humes HD (1980). Inhibitory effect of gentamicin on renal mitochondrial oxidative phosphorylation. J. Pharmacol. Exp. Ther.214:709–715.
129.
129. Soberon L, Bowan RL, Pastoriza-Munoz E, and Kaloyanides GJ (1979). Comparative nephrotoxicities of gentamicin, netilmicin, and tobramycin in the rat. J. Pharmacol. Exp. Ther.210:334–343.
130.
130. Solez K, Morel-Maroger L, and Sraer JD (1979). The morphology of “acute tubular necrosis” in man: Analysis of 57 renal biopsies and comparison with the glycerol model. Medicine58:362–376.
131.
131. Solez K, Racusen LC, and Olsen S (1983). The pathology of drug nephrotoxicity. J. Clin. Pharmacol.23:484–490.
132.
132. Solez K (1983). Acute renal failure. In: Pathology of the Kidney, RH Heptinstall. Little, Brown and Company, Boston/Toronto, Vol. II, pp. 1069–1148.
133.
133. Spring M (1951). Purpura and nephritis after administration of procaine penicillin. J.A.M.A.147:1139–1141.
134.
134. Stein JH and Fadem SZ (1978). The renal circulation. J.A.M.A.239:1308–1312.
135.
135. Suzuki T, Furusato M, Takasaki S, and Ishikawa E (1975). Giant mitochondria in epithelial cells of the proximal convoluted tubules of diseased human kidneys. Lab. Invest.33:578–590.
136.
136. Tadavarthy SM, Castancda W, and Amplatz K (1977). Redistribution of renal blood flow caused by contrast media. Radiology122:343–348.
137.
137. Takacs FJ, Tomkiewicz ZM, and Merrill JP (1963). Amphotericin B nephrotoxicity with irreversible renal failure. Ann. Intern. Med.59:716–724.
138.
138. Talner LB and Davidson AJ (1968). Renal hemo-dynamic effects of contrast media. Invest. Radiol, 3: 301–309.
139.
139. Tan SY, Shapiro R, and Kish MA (1979). Reversible acute renal failure induced by indomethacin. J.A.M.A.241:2732–2733.
140.
140. Teruel JL, Marcen R, Onaindia JM, Serrano A, Quereda C, and Ortuno J (1981). Renal function impairment caused by intravenous urography: A prospective study. Arch. Intern. Med.141:1271–1274.
141.
141. Tulkens PM, DeBroe ME, Maldague P, and Heuson-Stiennon J-A (1984). Lysosomal alterations in aminoglycoside-induced acute renal failure. In: Acute Renal Failure: Correlations Between Morphology and Function, K Solez and A Whelton (eds). Marcel Dekker, Inc., New York, pp. 299–330.
142.
142. Tune BM (1975). Relationship between the transport and toxicity of cephalosporins in the kidney. J. Infect. Dis.132:189–194.
143.
143. Tune BM, Wu KY, Longerbeam D, and Holtzman D (1978). Renal transport and toxicity of cephalosporins, including effects in tubular and mitochondrial respiration. Proceedings of VIIth International Congress of Nephrology, Montreal, pp. 279–287.
144.
144. Van den Berg EK Jr, Brazy PC, Huang AT, and Dennis VW (1981). Cis-platinum-induced changes in sodium, chloride, and urea transport by the frog skin. Kidney Int.19:8–14.
145.
145. Vanderwegham JL and Evan-Adin D (1982). Epidemiology of analgesic nephritis in Belgium. Clin. Nephrol.17:129–133.
146.
146. Van Zee BE, Hoy WE, Talley TE, and Jaenike JR (1978). Renal injury associated with IV pyelography in nondiabetic and diabetic patients. Ann. Intern. Med.89:51–54.
147.
147. Venkatachalam MA, Levinsky NG, and Jones DB (1984). Proximal tubular brush border alterations in experimental acute renal failure. In: Acute Renal Failure: Correlations Between Morphology and Function, K Solez and A Whelton (eds). Marcel Dekker, Inc., New York, pp. 97–103.
148.
148. Van Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rosencweig M, Young RC, and Muggia FM (1979). Toxic effects of cis-dichlorodiammine-platinum (II) in man. Cancer Treat. Rep.63:1527–1531.
149.
149. Ward JM and Fauvre KA (1976). The nephrotoxic effects of cis-diamminedichloroplatinum (II) (NSC-119875) in male sF344 rats. Toxicol. Appl. Pharmacol.38:535–547.
150.
150. Weinberg JM and Humes HD (1980). Mechanisms of gentamicin-induced dysfunction of renal cortical mitocondria. Arch. Biochem. Biophys.205:222–231.
151.
151. Weinberg JM and Humes HD (1984). Renal tubular cell integrity in mercuric chloride and gentamicin nephrotoxicity. In: Acute Renal Failure: Correlations Between Morphology and Function, K Solez and A Whelton (eds). Marcel Dekker, Inc., New York, pp. 179–194.
152.
152. Weinrauch LA, Healy RW, Leland OS Jr, Goldstein HH, Kassissieh SD, Libertino JA, Takacs FJ, and D'Elia JA (1977). Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann. Intern. Med.86:56–59.
153.
153. Weisman JI and Bloom B (1955). Anuria following phenylbutazone therapy. N. Engl. J. Med.252:1086–1087.
154.
154. Wellwood JM, Simpson PM, Tighe JR, and Thompson AE (1975). Evidence of gentamicin nephrotoxicity in patients with renal allografts. Br. Med. J.3:278–281.
155.
155. Wendland ML, Wagoner RD, and Holley KE (1980). Renal failure associated with fenoprofen. Mayo Clin. Proc.55:103–107.
156.
156. Westlake PT, Butler WT, Hill GJ, and Utz JP (1963). Nephrotoxic tubular damage and calcium deposition following amphotericin B therapy. Am. J. Pathol.43:449–457.
157.
157. Whelton A and Solez K (1982). Aminoglycoside nephrotoxicity—A tale of two transports. J. Lab. Clin. Med.99:148–155.
158.
158. Whelton A and Solez K (1981). Mechanisms of drug nephrotoxicity with special reference to the aminoglycosides. Proceedings of the VIIIth Congress of Nephrology, Athens, S. Karger, Basel, pp. 738–744.
159.
159. Whelton A and Solez K (1983). Pathophysiologic mechanisms in aminoglycoside nephrotoxicity. J. Clin. Pharmacol.23:453–460.
160.
160. Whiting PH, Thomson AW, Blair JT, and Simpson JG (1982). Experimental cyclosporin A nephrotoxicity. Br. J. Exp. Pathol.63:88–94.
161.
161. Zambraski EJ and Dunn MJ (1981). Prostaglandins and renal function in chronic bile duct-ligated cirrhotic dogs. Kidney Int.19: 218A.
162.
162. Zipser RD, Hoefs JC, Speckart PF, Zia P, and Horton R (1979). Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease. J. Clin. Endocrinol. Metabol.48:895–900.
